Previous 10 | Next 10 |
Gainers: Second Sight Medical Products (EYES) +337%.AMTD International (HKIB) +27%.Sify Technologies Limited (SIFY) +26%.Boqii Holding Limited (BQ) +25%.ChromaDex Corporation (CDXC) +22%.W&T Offshore (WTI) +21%.Anchiano Therapeutics (ANCN) +18%.Purple Innovation (PRPL) +19%.Plus Ther...
XTL Biopharmaceuticals (XTLB) +93%.Second Sight Medical Products, Inc. (EYES) +50%.Fulgent Genetics, Inc. (FLGT) +32% on Q4 results.CLPS Incorporation (CLPS) +29% on FQ2 results.Sify Technologies Limited (SIFY) +26% on report of Blackstone buying minority stake.Waitr Holdings (...
Second Sight Medical Products (EYES) has climbed ~47.6% in the premarket after the company announced that the FDA has approved Argus 2s retinal prosthesis system.On electrical stimulation, the system bypasses the defunct retinal cells to stimulate remaining viable cells to...
Second Sight Medical Products (NASDAQ:EYES) a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced U.S. Food and Drug Administration (FDA) has approved the Argus 2s Retinal...
Helius Medical Technologies (HSDT) -17%.Avinger (AVGR) -12%.Cango (CANG) -11%.OncoCyte (OCX) -10%.Obalon Therapeutics (OBLN) -10%.Dolphin Entertainment (DLPN) -9%.Surgalign Holdings (SRGA) -8% after pricing equity offering at $1.50.Vertex Energy (VTNR) -7%.Atossa Therapeutics (ATOS)...
After a 38% rise in the premarket Second Sight Medical Products (EYES) is up ~17.9% today in an apparent reaction to a patent win by the company.Entitled "Uses for eye tracking in a visual prosthesis," the patent has been issued today according to the database of USPTO (th...
Edesa Biotech (EDSA) +97% on regulatory nod for sub set of phase2/3 EB05 COVID-19 study.Koss Corporation (KOSS) +84%.Phunware (PHUN) +65%.Vertex Energy (VTNR) +52%.Myomo (MYO) +33% on JV to manufacture and sell the company’s products in China.AIkido Pharma (AIKI) +2...
Analysts Rate These Penny Stocks A Buy Right Now The thought of making money with penny stocks is always the favored goal, right? It’s simple, just buy then sell for a profit. But as easy as that sounds, there’s a lot more that goes into the actual strategy of day trad...
Gainers: Isoray (ISR) +187%.The9 (NCTY) +48%.9 Meters Biopharma (NMTR) +40%.AIkido Pharma (AIKI) +40%.Guardion Health Sciences (GHSI) +38%.TAT Technologies (TATT) +35%.Orchard Therapeutics (ORTX) +35%.Change Healthcare (CHNG) +31%.CleanSpark (CLSK) +30%.CBAK Ener...
Gainers: Isoray (ISR) +181%, Guardion Health Sciences (GHSI) +57%, AIkido Pharma AIKI +57%, Orchard Therapeutics ORTX +41%, Change Healthcare CHNG +31%.Losers: IMARA IMRA -35%, Synthetic Biologics (SYN) -25%, Second Sight Medical Pro...
News, Short Squeeze, Breakout and More Instantly...
Second Sight Medical Products Inc. Company Name:
EYES Stock Symbol:
NASDAQ Market:
Second Sight to change its name to Vivani Medical, Inc. Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of u...
Grant proceeds support an ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial for...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...